AI-Powered Handheld Microscope Could Boost Early Cancer Detection
AI-Powered Handheld Microscope Could Boost Early Cancer Detection
Researchers from Rice University and The University of Texas MD Anderson Cancer Center have developed a portable AI-powered microscope designed to improve early cancer detection by providing high-resolution imaging in real time.
The device, called PrecisionView, was detailed in a new study published in the Proceedings of the National Academy of Sciences. About the size of a pen, the handheld endomicroscope combines advanced optics with artificial intelligence to help doctors examine tissue without relying heavily on invasive biopsies.
According to the researchers, PrecisionView can visualize both tiny cellular structures and blood vessels beneath tissue surfaces, allowing clinicians to identify potential cancerous changes more accurately across larger areas of tissue.
Rebecca Richards-Kortum, the study’s corresponding author and co-director of the Rice360 Institute for Global Health Technologies, said the technology addresses a major limitation in current cancer screening tools.
“Early detection is one of the most critical factors in improving cancer outcomes, but today’s tools often force clinicians to choose between detail and coverage,” Richards-Kortum explained. “With PrecisionView, we no longer have to make that trade-off.”
The device uses a custom-designed optical phase mask alongside an AI reconstruction algorithm to expand imaging performance. Researchers say the system delivers a viewing area about five times larger and a depth of field roughly eight times greater than conventional handheld microscopes while still maintaining cellular-level resolution.
Ashok Veeraraghavan, co-author of the study, said the project differs from traditional AI-enhanced imaging because artificial intelligence was used to redesign the microscope’s optics themselves rather than simply improving images after capture.
The technology was tested on healthy volunteers and tissue samples containing precancerous lesions. In one experiment, PrecisionView scanned oral tissue and produced detailed maps of tissue structures and blood vessels over areas larger than one square centimeter. In another, the device successfully identified abnormal cervical tissue linked to precancerous changes.
Researchers say the system could eventually help doctors guide biopsies, improve routine cancer screenings, and reduce missed diagnoses.
Designed to be affordable and accessible, PrecisionView costs around $3,000 to build, making it potentially useful in low-resource clinics where access to advanced pathology services is limited.
Kathleen Schmeler noted that the technology could have a major impact in underserved communities by bringing high-quality diagnostic tools directly to the point of care.
While larger clinical studies are still needed before widespread adoption, the researchers believe PrecisionView represents a major step toward combining AI and optical engineering to improve medical diagnostics and patient outcomes.
